TransFlex human OCT2 (SLC22A2) plates are available in a 96-well format with variable plate configurations. The plates are ready to use after an overnight incubation—no change of medium required.
TransFlex-OCT2 plate performance is demonstrated by the OCT2-mediated transport of metformin, and the inhibition of that transport by the OCT2 inhibitor quinidine.
|Catalog Number||Plate Configuration|
|TFlex-OCT2||Half of the wells contain OCT2-expressing cells, and half contain control cells.|
|TFlex-OCT2-F||All of the wells contain OCT2-expressing cells.|
|TFlex-MDCK-C||All of the wells contain control cells.|
|TFlex-Pick2||Custom format: plate contains two transporters of your choice, plus control cells.|
|TFlex-Pick4||Custom format: plate contains four transporters of your choice, plus control cells.|
Please contact us for more information.